Skip to content
Quant500 - Quantitative Analysis
Search ticker or company...
ES | EN

Company Profile: The Cigna Group (CI)

CI insider trades (13 months) →

$295.44 +0.08% vs. previous close · Market cap $78.07B

Today's multi-factor rank: 109 of 461 · see the ranking

Momentum
5.2/10
Value
7.6/10
Growth
4.6/10
Quality
4.0/10
Multifactor
5.3/10

Market and Valuation

Price & Market

Prev Close Price:$295.19
Open:$293.72
Day's Low:$293.21
Day's High:$297.68
Bid / Ask:-
Market Cap:78.07B
Enterprise Value:102.91B

52-Week Range

52-Week Low:$255.53
52-Week High:$316.27
Current position in 52-week range
52w Low-52w High
50-Day Avg:$284.26
200-Day Avg:$281.74

Volume

Volume Today:1,812,933
Avg Volume (3m):1,610,056
Avg Volume (10d):1,490,630
52-Week Change:+11.54%
vs S&P 500, 52 weeks:-
Beta:0.25

Valuation Multiples

P/E (trailing):12.21

Diluted EPS for the last 12 months: the four quarters ended Jun 30, 2026, from the accounts filed with the SEC on Jul 30, 2026. The P/E is the price divided by that EPS.

P/E (forward):8.82
PEG Ratio:0.81
Price / Book:1.83
Price / Sales (TTM):0.28
EV / Revenue:0.36
EV / EBITDA:8.07

Dividends

Current yield:2.11%
Annual Dividend Rate:$6.24
Dividend Trailing:$6.14
Yield Trailing:2.08%
5-Year Avg Yield:1.73%
Payout Ratio:25.38%
Last Ex-Dividend Date:-

Valuation Context

P/E vs sector (indicative)

Most Recent Quarter:-
Fiscal Year (Next):-

Loading historical OHLCV database...

Financial Statements TTM (Trailing 12 Months)

Income Statement

Total Revenue (TTM):282.38B
Gross Profit:25.80B
EBITDA:12.76B
Net Income (TTM):6.42B
Rev Growth (YoY):+6.70%
Earnings Growth (YoY):+10.20%
Quarterly earnings growth (YoY):+8.40%

Margins

Gross Margin:-
EBITDA Margin:-
Operating Margin:-
Net Margin:-

Per Share

EPS Trailing (TTM):$24.19

Diluted EPS for the last 12 months: the four quarters ended Jun 30, 2026, from the accounts filed with the SEC on Jul 30, 2026. The P/E is the price divided by that EPS.

EPS Forward (Est.):$33.49
Revenue Per Share:$1,069.95
Cash Per Share:-
Book Value:$161.62
Last Dividend:-
Ex-Dividend Date:-
Last Split:-

Balance Sheet & Liquidity

Total cash:7.26B
Total Debt:31.88B
Net Debt (Debt - Cash):24.62B
Debt / Equity:74.29%
Current Ratio:0.85
Quick Ratio:0.69

Cash Flows

Operating Cash Flow:10.28B
Free Cash Flow (FCF):7.98B
FCF Yield (FCF / Market Cap):-
Enterprise Value:102.91B
EV / Revenue:0.36
EV / EBITDA:8.07

Profitability

ROE (Return on Equity):16.76%
ROA (Return on Assets):4.46%
P/E (trailing):12.21
P/E (forward):8.82
Price / Book:1.83
PEG Ratio:0.81
52-Week Change:+11.54%
S&P 500 change, 52 weeks:+11.37%

Historical Evolution (Last 4 Years)

Income Statement

Balance Sheet

Cash Flow

EPS and Earnings Per Share

Key EPS Metrics

EPS Trailing (TTM):$24.19

Diluted EPS for the last 12 months: the four quarters ended Jun 30, 2026, from the accounts filed with the SEC on Jul 30, 2026. The P/E is the price divided by that EPS.

EPS Forward (Est.):$33.49
P/E (forward):8.82
PEG Ratio:0.81

Growth and Margins

Earnings Growth YoY:-
Quarterly Earnings Growth YoY:-
Rev Growth YoY:-
Net Margin:-
Gross Margin:-
EBITDA Margin:-

Per Share

Revenue Per Share:$1,069.95
Cash Per Share:-
Book Value:$161.62

Cash Flows (TTM)

Free Cash Flow:7.98B
Operating Cash Flow:10.28B
EBITDA:12.76B
Total Revenue (TTM):282.38B
Net Income (TTM):6.42B
Fiscal Year (Last):-

EPS Surprise History - Last 4 Quarters

Actual vs. Analyst Estimates · Green = beat expectations · Red = missed

Quarter Period Actual EPS Estimated EPS Difference Surprise % Currency

Ownership Structure

Ownership Distribution

% Insiders:-
% Institutional:-
% Inst. (of Float):-
No. of Institutions:-
Visual distribution
InsidersInstitutionalFree Float

Shares & Short Interest

Shares Outstanding:264,240,486
Float (free shares):262,935,138
Short interest (shares):6,757,391
Short % of float:-
Short Ratio (days to cover):4.15
Short interest, prior month:-
Short Interest Date:-

Governance Score (1=Best, 10=Worst)

Overall risk:-
Audit Risk:-
Board risk:-
Compensation Risk:-
Shareholder rights risk:-

Top Institutional Holders

Position Change: ▲ Increased · ▼ Reduced · = Unchanged

Organization Report Date % Shares No. Shares Value (USD) Change %

Top Mutual Funds

Position Change: ▲ Increased ▼ Decreased = Unchanged

Fund Report Date % Shares No. Shares Value (USD) Change %

Recent Insider Trades

Executive / Insider Title Date Action Shares

Options Chain

CALLS

StrikeLastBidAskVol.O.I.IV

PUTS

StrikeLastBidAskVol.O.I.IV

The Cigna Group (CI) SEC filings: 10-K, 10-Q and 8-K

Direct links to financial reports filed with the SEC.

Type Date Official link
8-K2026-10-09View filing ↗
8-K2026-09-30View filing ↗
10-Q2026-07-30View filing ↗
11-K2026-06-24View filing ↗
8-K2026-05-13View filing ↗
10-Q2026-04-30View filing ↗
8-K2026-04-27View filing ↗
ARS2026-03-13View filing ↗
8-K2026-03-03View filing ↗
8-K2026-02-27View filing ↗

Company and Executive Profile

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. It operates through two segments: Evernorth Health Services and Cigna Healthcare. The Evernorth Health Services segment includes Pharmacy Benefit Services and Specialty and Care Services, offering pharmacy benefit management, drug claim adjudication, retail pharmacy network administration, benefit design consultation, drug utilization review, drug formulary management, pharmacy benefits, home delivery pharmacy, specialty pharmacy, specialty pharmaceutical distribution, and clinical programs for whole-person health outcomes. The Cigna Healthcare segment comprises U.S. Healthcare and International Health, delivering comprehensive medical and coordinated solutions such as employer medical plans, individual and family plans, behavioral health, consumer health engagement, dental, pharmacy management, stop-loss insurance, global health care, and local health care solutions, as well as health care benefits for mobile individuals and employees of multinational organizations. The company offers other operations, including corporate-owned life insurance, reinsurance, and certain run-off and non-strategic businesses. The company distributes its products and services through brokers and consultants; directly to employers, unions and other groups, or individuals; and private and public exchanges. The company was formerly known as Cigna Corporation and changed its name to The Cigna Group in February 2023. The company was founded in 1792 and is headquartered in Bloomfield, Connecticut.

General Information

Headquarters:United States
City:Bloomfield
Employees:65,669
Sector:Healthcare
Industry:Healthcare Plans
Website:-

Key Executives

NameTitleAgeTotal pay
Mr. David Michael CordaniExecutive Chairman of the Board605.44M
Mr. Brian Case Evanko C.F.A.President, CEO & Director483.28M
Ms. Ann M. DennisonExecutive VP & CFO541.88M
Ms. Nicole Susan Jones J.D.Executive Vice President, Chief Administrative Officer & Chief Human Resources Officer542.03M
Mr. F. Everett NevilleExecutive VP & Special Advisor to the CEO601.84M
Ms. Jamie KatesSenior VP & Tax and Global Chief Accounting Officer45-
Mr. Durga Prasad KokaExecutive Vice President & Global Chief Information Officer--
Mr. Ralph GiacobbeSenior Vice President of Investor Relations--

You have seen the engine room

A free account saves your simulator portfolios, your personal portfolio and your Academy progress, synced across devices. And, if you switch it on, the email alert the same day an insider buys stock in their own company.

No card. No spam.

The Cigna Group (CI): Quantitative Analysis

The Cigna Group (CI) — Healthcare — Healthcare Plans. CI is in the S&P 500 today. Model factor scores and market data, recalculated every trading day.

So far in 2026, CI has returned +9.0% against +11.4% for the S&P 500 (SPY): total return, dividends included on both sides, from Dec 31, 2025 to Nov 3, 2026.

CI ranks 109 of 461 on today's multifactor score, and 10 of the 55 Healthcare companies that score. Its strongest factor is value (Z 1.54, ranked 16 of 489); its weakest is quality (Z -0.57, ranked 405 of 468). Each factor ranks only the companies with data for it, and the multifactor score only those with all four: that is why the totals differ.

Factor scores

The Z-Score is how many standard deviations the company sits from the index average: 0 is average, positive is better than average, negative is worse.

FactorZ-ScoreRank
Multifactor0.205109 of 461
Momentum0.094200 of 494 ↑17
Value1.54316 of 489 ↓4
Quality-0.572405 of 468
Growth-0.245296 of 489

Market data

MetricValue
Price$295.44
Market Cap78.07B
P/E12.21
Revenue (last 12 months)282.38B
Price / book1.83
Book value per share$161.62
52-week range$255.53 – $316.27
Dividend yield2.11%
Beta0.25
Average volume1,610,056
Shares outstanding264.24M
Short interest (% of float)2.85% (as of Oct 15, 2026)

When does CI report earnings? 12 of its last 12, before the open →

What are CI insiders doing? 43 transactions filed with the SEC, of them 1 buy and 8 sells, the last one on Sep 3, 2026 →

CI latest SEC filings

Filing dates on EDGAR, the SEC's public registry. All CI filings on EDGAR.

Guides: How to read a Quant500 company page · What the S&P 500 is · P/E ratio explained · 10-K, 10-Q and 8-K · all guides

Frequently asked questions about Cigna (CI)

When does Cigna report earnings?

According to Nasdaq's public calendar (checked on Nov 4, 2026), Cigna will report its next earnings on Nov 5, 2026, before the US market opens. The date is announced by the company itself and can change. Of its last 12 earnings announcements: 12 before the open (SEC filings through Jul 30, 2026). CI earnings dates and times, quarter by quarter →

What is Cigna's P/E ratio?

Cigna's P/E (price over earnings per share for the last twelve months) is 12.2 at the Nov 3, 2026 close. That EPS is the 12-month diluted figure from the SEC, the four quarters ended Jun 30, 2026. The median of the 54 Healthcare companies with a P/E is 30.5, and the S&P 500's, 23.5: Cigna is below its sector median. Healthcare stocks, company by company →

Where does Cigna rank on Quant500?

In the Nov 3, 2026 multi-factor ranking, Cigna ranks 109 of 461, and 10 of the 55 Healthcare companies that score. The ranking orders S&P 500 companies by the average of four factors (momentum, value, quality and growth) and is recalculated every trading day. It is a model output, not investment advice. The full ranking → How it is calculated →

Have Cigna insiders bought or sold shares?

The latest open-market purchase of Cigna shares filed with the SEC (Form 4) was on Nov 3, 2025, by a director who is also an officer, for $1.0M. The latest sale was on Sep 3, 2026, by an officer, for $175k. In total, from August 2025 through Nov 3, 2026: 1 purchase and 8 sales by directors, officers and large shareholders. All CI insider trades →

Does Cigna pay a dividend?

Yes. Its dividend yield is 2.11% at the Nov 3, 2026 close (annual dividend of $6.24 per share). The next announced ex-dividend date is Dec 3, 2026.

What sector is Cigna in, and which index?

Cigna is classified in the Healthcare sector (industry: Healthcare Plans), per the data provider's classification (similar to GICS, not identical). It is in the S&P 500 today. It is one of the 59 S&P 500 companies in that sector. Healthcare stocks →

What is behind these numbers

The concepts on this page, explained from scratch in the Academy. Free, no account.

The whole Academy, course by course →

Data as of Nov 3, 2026. Source: point-in-time SEC fundamentals and closing prices. Method and formulas are on the home page.

The model portfolio, weekly in your inbox

Every Saturday, its week in one minute: how it went, the best and the worst, and which insiders bought with their own money. Plus, the day the model is rebuilt, which stocks come in and which go out. A simulation, not advice. At most one email a week, no ads, no account; one-click unsubscribe. Made by one person: Pol Gracia.

A model portfolio with simulated results, not a personalized recommendation. Your email is used for this only: privacy.

S&P 500 market gravity